Comparison 3 Misoprostol versus placebo/no treatment: all women, intact membranes, unfavourable cervix, Outcome 11 Apgar score
Comparison 3 Misoprostol versus placebo/no treatment: all women, intact membranes, unfavourable cervix, Outcome 12 Neonatal intensive care unit admission.
Comparison 3 Misoprostol versus placebo/no treatment: all women, intact membranes, unfavourable cervix, Outcome 13 Perinatal death.
Comparison 3 Misoprostol versus placebo/no treatment: all women, intact membranes, unfavourable cervix, Outcome 14 Maternal side effects.
Comparison 3 Misoprostol versus placebo/no treatment: all women, intact membranes, unfavourable cervix, Outcome 15 Postpartum haemorrhage.
Comparison 3 Misoprostol versus placebo/no treatment: all women, intact membranes, unfavourable cervix, Outcome 16 Serious maternal complication.
Comparison 3 Misoprostol versus placebo/no treatment: all women, intact membranes, unfavourable cervix, Outcome 17 Maternal death.
Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined cervix, Outcome 1 Uterine hyperstimulation with FHR changes.
Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined cervix, Outcome 2 Vaginal delivery not achieved in 24 hours.
Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined cervix, Outcome 3 Caesarean section.
Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined cervix, Outcome 4 Apgar score
4.5. Analysis
Comparison 4 Misoprostol versus placebo/no…
4.5. Analysis
Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined…
4.5. Analysis Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined cervix, Outcome 5 Neonatal intensive care unit admission.
4.6. Analysis
Comparison 4 Misoprostol versus placebo/no…
4.6. Analysis
Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined…
4.6. Analysis Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined cervix, Outcome 6 Neonatal encephalopathy.
4.7. Analysis
Comparison 4 Misoprostol versus placebo/no…
4.7. Analysis
Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined…
4.7. Analysis Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined cervix, Outcome 7 Oxytocin augmentation.
4.8. Analysis
Comparison 4 Misoprostol versus placebo/no…
4.8. Analysis
Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined…
4.8. Analysis Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined cervix, Outcome 8 Serious maternal complications.
4.9. Analysis
Comparison 4 Misoprostol versus placebo/no…
4.9. Analysis
Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined…
4.9. Analysis Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined cervix, Outcome 9 Perinatal death.
4.10. Analysis
Comparison 4 Misoprostol versus placebo/no…
4.10. Analysis
Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined…
4.10. Analysis Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined cervix, Outcome 10 Instrumental delivery.
4.11. Analysis
Comparison 4 Misoprostol versus placebo/no…
4.11. Analysis
Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined…
4.11. Analysis Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined cervix, Outcome 11 Postpartum haemorrhage.
4.12. Analysis
Comparison 4 Misoprostol versus placebo/no…
4.12. Analysis
Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined…
4.12. Analysis Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined cervix, Outcome 12 Meconium‐stained liquor.
4.13. Analysis
Comparison 4 Misoprostol versus placebo/no…
4.13. Analysis
Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined…
4.13. Analysis Comparison 4 Misoprostol versus placebo/no treatment: all women, ruptured membranes, variable or undefined cervix, Outcome 13 Uterine hyperstimulation without FHR changes.
5.1. Analysis
Comparison 5 Misoprostol versus placebo/no…
5.1. Analysis
Comparison 5 Misoprostol versus placebo/no treatment: all primiparae, Outcome 1 Caesarean section.
5.1. Analysis Comparison 5 Misoprostol versus placebo/no treatment: all primiparae, Outcome 1 Caesarean section.
6.1. Analysis
Comparison 6 Misoprostol versus placebo/no…
6.1. Analysis
Comparison 6 Misoprostol versus placebo/no treatment: all primiparae and unfavourable cervix, Outcome 1…
6.1. Analysis Comparison 6 Misoprostol versus placebo/no treatment: all primiparae and unfavourable cervix, Outcome 1 Caesarean section.
7.1. Analysis
Comparison 7 Misoprostol versus placebo/no…
7.1. Analysis
Comparison 7 Misoprostol versus placebo/no treatment: all primiparae, intact membranes and unfavourable cervix,…
7.1. Analysis Comparison 7 Misoprostol versus placebo/no treatment: all primiparae, intact membranes and unfavourable cervix, Outcome 1 Caesarean section.
9.1. Analysis
Comparison 9 Misoprostol versus placebo/no…
9.1. Analysis
Comparison 9 Misoprostol versus placebo/no treatment: all multiparous and unfavourable cervix, Outcome 1…
9.1. Analysis Comparison 9 Misoprostol versus placebo/no treatment: all multiparous and unfavourable cervix, Outcome 1 Caesarean section.
10.1. Analysis
Comparison 10 Misoprostol versus placebo/no…
10.1. Analysis
Comparison 10 Misoprostol versus placebo/no treatment: all multiparous, intact membranes and unfavourable cervix,…
10.1. Analysis Comparison 10 Misoprostol versus placebo/no treatment: all multiparous, intact membranes and unfavourable cervix, Outcome 1 Caesarean section.
11.1. Analysis
Comparison 11 Misoprostol versus vaginal…
11.1. Analysis
Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 1 Vaginal delivery not…
11.1. Analysis Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 1 Vaginal delivery not achieved within 24 hours.
11.2. Analysis
Comparison 11 Misoprostol versus vaginal…
11.2. Analysis
Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 2 Uterine hyperstimulation with…
11.2. Analysis Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 2 Uterine hyperstimulation with FHR changes.
11.3. Analysis
Comparison 11 Misoprostol versus vaginal…
11.3. Analysis
Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 3 Caesarean section.
11.3. Analysis Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 3 Caesarean section.
11.4. Analysis
Comparison 11 Misoprostol versus vaginal…
11.4. Analysis
Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 4 Serious neonatal morbidity…
11.4. Analysis Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 4 Serious neonatal morbidity or perinatal death.
11.5. Analysis
Comparison 11 Misoprostol versus vaginal…
11.5. Analysis
Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 5 Serious maternal morbidity…
11.5. Analysis Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 5 Serious maternal morbidity or death.
11.6. Analysis
Comparison 11 Misoprostol versus vaginal…
11.6. Analysis
Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 6 Cervix unfavourable/unchanged after…
11.6. Analysis Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 6 Cervix unfavourable/unchanged after 12‐24 hours.
11.7. Analysis
Comparison 11 Misoprostol versus vaginal…
11.7. Analysis
Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 7 Oxytocin augmentation.
11.7. Analysis Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 7 Oxytocin augmentation.
11.8. Analysis
Comparison 11 Misoprostol versus vaginal…
11.8. Analysis
Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 8 Uterine hyperstimulation without…
11.8. Analysis Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 8 Uterine hyperstimulation without FHR changes.
11.9. Analysis
Comparison 11 Misoprostol versus vaginal…
11.9. Analysis
Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 9 Uterine rupture.
11.9. Analysis Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 9 Uterine rupture.
11.10. Analysis
Comparison 11 Misoprostol versus vaginal…
11.10. Analysis
Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 10 Epidural analgesia.
11.10. Analysis Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 10 Epidural analgesia.
11.11. Analysis
Comparison 11 Misoprostol versus vaginal…
11.11. Analysis
Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 11 Instrumental vaginal delivery.
11.11. Analysis Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 11 Instrumental vaginal delivery.
11.12. Analysis
Comparison 11 Misoprostol versus vaginal…
11.12. Analysis
Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 12 Meconium‐stained liquor.
11.12. Analysis Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 12 Meconium‐stained liquor.
11.13. Analysis
Comparison 11 Misoprostol versus vaginal…
11.13. Analysis
Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 13 Apgar score
11.13. Analysis Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 13 Apgar score
11.14. Analysis
Comparison 11 Misoprostol versus vaginal…
11.14. Analysis
Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 14 Neonatal intensive care…
11.14. Analysis Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 14 Neonatal intensive care unit admission.
11.15. Analysis
Comparison 11 Misoprostol versus vaginal…
11.15. Analysis
Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 15 Neonatal encephalopathy.
11.15. Analysis Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 15 Neonatal encephalopathy.
11.16. Analysis
Comparison 11 Misoprostol versus vaginal…
11.16. Analysis
Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 16 Perinatal death.
11.16. Analysis Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 16 Perinatal death.
11.17. Analysis
Comparison 11 Misoprostol versus vaginal…
11.17. Analysis
Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 17 Serious maternal complications.
11.17. Analysis Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 17 Serious maternal complications.
11.18. Analysis
Comparison 11 Misoprostol versus vaginal…
11.18. Analysis
Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 18 Maternal side effects…
11.18. Analysis Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 18 Maternal side effects (eg nausea, vomiting, diarrhoea).
11.19. Analysis
Comparison 11 Misoprostol versus vaginal…
11.19. Analysis
Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 19 Postpartum haemorrhage.
11.19. Analysis Comparison 11 Misoprostol versus vaginal prostaglandin: all women, Outcome 19 Postpartum haemorrhage.
12.1. Analysis
Comparison 12 Misoprostol versus vaginal…
12.1. Analysis
Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 1 Vaginal…
12.1. Analysis Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 1 Vaginal delivery not achieved within 24 hours.
12.2. Analysis
Comparison 12 Misoprostol versus vaginal…
12.2. Analysis
Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 2 Uterine…
12.2. Analysis Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 2 Uterine hyperstimulation with FHR changes.
12.3. Analysis
Comparison 12 Misoprostol versus vaginal…
12.3. Analysis
Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 3 Caesarean…
12.3. Analysis Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 3 Caesarean section.
12.4. Analysis
Comparison 12 Misoprostol versus vaginal…
12.4. Analysis
Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 4 Serious…
12.4. Analysis Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 4 Serious neonatal morbidity or perinatal death.
12.5. Analysis
Comparison 12 Misoprostol versus vaginal…
12.5. Analysis
Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 5 Uterine…
12.5. Analysis Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 5 Uterine rupture.
12.6. Analysis
Comparison 12 Misoprostol versus vaginal…
12.6. Analysis
Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 6 Cervix…
12.6. Analysis Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 6 Cervix unfavourable/unchanged after 12‐24 hours.
12.7. Analysis
Comparison 12 Misoprostol versus vaginal…
12.7. Analysis
Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 7 Oxytocin…
12.7. Analysis Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 7 Oxytocin augmentation.
12.8. Analysis
Comparison 12 Misoprostol versus vaginal…
12.8. Analysis
Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 8 Uterine…
12.8. Analysis Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 8 Uterine hyperstimulation without FHR changes.
12.9. Analysis
Comparison 12 Misoprostol versus vaginal…
12.9. Analysis
Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 9 Serious…
12.9. Analysis Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 9 Serious maternal morbidity or death.
12.10. Analysis
Comparison 12 Misoprostol versus vaginal…
12.10. Analysis
Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 10 Epidural…
12.10. Analysis Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 10 Epidural analgesia.
12.11. Analysis
Comparison 12 Misoprostol versus vaginal…
12.11. Analysis
Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 11 Instrumental…
12.11. Analysis Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 11 Instrumental vaginal delivery.
12.12. Analysis
Comparison 12 Misoprostol versus vaginal…
12.12. Analysis
Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 12 Meconium‐stained…
12.12. Analysis Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 12 Meconium‐stained liquor.
12.13. Analysis
Comparison 12 Misoprostol versus vaginal…
12.13. Analysis
Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 13 Apgar…
12.13. Analysis Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 13 Apgar score
12.14. Analysis
Comparison 12 Misoprostol versus vaginal…
12.14. Analysis
Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 14 Neonatal…
12.14. Analysis Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 14 Neonatal intensive care unit admission.
12.15. Analysis
Comparison 12 Misoprostol versus vaginal…
12.15. Analysis
Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 15 Neonatal…
12.15. Analysis Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 15 Neonatal encephalopathy.
12.16. Analysis
Comparison 12 Misoprostol versus vaginal…
12.16. Analysis
Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 16 Perinatal…
12.16. Analysis Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 16 Perinatal death.
12.17. Analysis
Comparison 12 Misoprostol versus vaginal…
12.17. Analysis
Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 17 Serious…
12.17. Analysis Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 17 Serious maternal complications.
12.18. Analysis
Comparison 12 Misoprostol versus vaginal…
12.18. Analysis
Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 18 Maternal…
12.18. Analysis Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 18 Maternal side effects (eg nausea, vomiting, diarrhoea).
12.19. Analysis
Comparison 12 Misoprostol versus vaginal…
12.19. Analysis
Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 19 Postpartum…
12.19. Analysis Comparison 12 Misoprostol versus vaginal prostaglandin: all women, unfavourable cervix, Outcome 19 Postpartum haemorrhage.
13.1. Analysis
Comparison 13 Misoprostol versus vaginal…
13.1. Analysis
Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome…
13.1. Analysis Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome 1 Vaginal delivery not achieved within 24 hours.
13.2. Analysis
Comparison 13 Misoprostol versus vaginal…
13.2. Analysis
Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome…
13.2. Analysis Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome 2 Uterine hyperstimulation with FHR changes.
13.3. Analysis
Comparison 13 Misoprostol versus vaginal…
13.3. Analysis
Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome…
13.3. Analysis Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome 3 Caesarean section.
13.4. Analysis
Comparison 13 Misoprostol versus vaginal…
13.4. Analysis
Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome…
13.4. Analysis Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome 4 Serious neonatal morbidity or perinatal death.
13.5. Analysis
Comparison 13 Misoprostol versus vaginal…
13.5. Analysis
Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome…
13.5. Analysis Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours.
13.6. Analysis
Comparison 13 Misoprostol versus vaginal…
13.6. Analysis
Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome…
13.6. Analysis Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome 6 Oxytocin augmentation.
13.7. Analysis
Comparison 13 Misoprostol versus vaginal…
13.7. Analysis
Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome…
13.7. Analysis Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome 7 Uterine hyperstimulation without FHR changes.
13.8. Analysis
Comparison 13 Misoprostol versus vaginal…
13.8. Analysis
Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome…
13.8. Analysis Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome 8 Uterine rupture.
13.9. Analysis
Comparison 13 Misoprostol versus vaginal…
13.9. Analysis
Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome…
13.9. Analysis Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome 9 Epidural analgesia.
13.10. Analysis
Comparison 13 Misoprostol versus vaginal…
13.10. Analysis
Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome…
13.10. Analysis Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome 10 Instrumental vaginal delivery.
13.11. Analysis
Comparison 13 Misoprostol versus vaginal…
13.11. Analysis
Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome…
13.11. Analysis Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome 11 Meconium‐stained liquor.
13.12. Analysis
Comparison 13 Misoprostol versus vaginal…
13.12. Analysis
Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome…
13.12. Analysis Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome 12 Apgar score
13.13. Analysis
Comparison 13 Misoprostol versus vaginal…
13.13. Analysis
Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome…
13.13. Analysis Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome 13 Neonatal intensive care unit admission.
13.14. Analysis
Comparison 13 Misoprostol versus vaginal…
13.14. Analysis
Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome…
13.14. Analysis Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome 14 Neonatal encephalopathy.
13.15. Analysis
Comparison 13 Misoprostol versus vaginal…
13.15. Analysis
Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome…
13.15. Analysis Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome 15 Perinatal death.
13.16. Analysis
Comparison 13 Misoprostol versus vaginal…
13.16. Analysis
Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome…
13.16. Analysis Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome 16 Maternal side effects (eg nausea, vomiting, diarrhoea).
13.17. Analysis
Comparison 13 Misoprostol versus vaginal…
13.17. Analysis
Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome…
13.17. Analysis Comparison 13 Misoprostol versus vaginal prostaglandin: all women, intact membranes, unfavourable cervix, Outcome 17 Postpartum haemorrhage.
14.1. Analysis
Comparison 14 Misoprostol versus vaginal…
14.1. Analysis
Comparison 14 Misoprostol versus vaginal prostaglandin: all women, intact membranes, variable or undefined…
14.1. Analysis Comparison 14 Misoprostol versus vaginal prostaglandin: all women, intact membranes, variable or undefined cervix, Outcome 1 Uterine hyperstimulation with FHR changes.
14.2. Analysis
Comparison 14 Misoprostol versus vaginal…
14.2. Analysis
Comparison 14 Misoprostol versus vaginal prostaglandin: all women, intact membranes, variable or undefined…
14.2. Analysis Comparison 14 Misoprostol versus vaginal prostaglandin: all women, intact membranes, variable or undefined cervix, Outcome 2 Caesarean section.
14.3. Analysis
Comparison 14 Misoprostol versus vaginal…
14.3. Analysis
Comparison 14 Misoprostol versus vaginal prostaglandin: all women, intact membranes, variable or undefined…
14.3. Analysis Comparison 14 Misoprostol versus vaginal prostaglandin: all women, intact membranes, variable or undefined cervix, Outcome 3 Oxytocin augmentation.
14.4. Analysis
Comparison 14 Misoprostol versus vaginal…
14.4. Analysis
Comparison 14 Misoprostol versus vaginal prostaglandin: all women, intact membranes, variable or undefined…
14.4. Analysis Comparison 14 Misoprostol versus vaginal prostaglandin: all women, intact membranes, variable or undefined cervix, Outcome 4 Uterine hyperstimulation without FHR changes.
14.5. Analysis
Comparison 14 Misoprostol versus vaginal…
14.5. Analysis
Comparison 14 Misoprostol versus vaginal prostaglandin: all women, intact membranes, variable or undefined…
14.5. Analysis Comparison 14 Misoprostol versus vaginal prostaglandin: all women, intact membranes, variable or undefined cervix, Outcome 5 Epidural analgesia.
14.6. Analysis
Comparison 14 Misoprostol versus vaginal…
14.6. Analysis
Comparison 14 Misoprostol versus vaginal prostaglandin: all women, intact membranes, variable or undefined…
14.6. Analysis Comparison 14 Misoprostol versus vaginal prostaglandin: all women, intact membranes, variable or undefined cervix, Outcome 6 Instrumental vaginal delivery.
14.7. Analysis
Comparison 14 Misoprostol versus vaginal…
14.7. Analysis
Comparison 14 Misoprostol versus vaginal prostaglandin: all women, intact membranes, variable or undefined…
14.7. Analysis Comparison 14 Misoprostol versus vaginal prostaglandin: all women, intact membranes, variable or undefined cervix, Outcome 7 Perinatal death.
15.1. Analysis
Comparison 15 Misoprostol versus vaginal…
15.1. Analysis
Comparison 15 Misoprostol versus vaginal prostaglandin: all women with ruptured membranes and unfavourable…
15.1. Analysis Comparison 15 Misoprostol versus vaginal prostaglandin: all women with ruptured membranes and unfavourable cervix, Outcome 1 Caesarean section.
15.2. Analysis
Comparison 15 Misoprostol versus vaginal…
15.2. Analysis
Comparison 15 Misoprostol versus vaginal prostaglandin: all women with ruptured membranes and unfavourable…
15.2. Analysis Comparison 15 Misoprostol versus vaginal prostaglandin: all women with ruptured membranes and unfavourable cervix, Outcome 2 Uterine hyperstimulation with FHR changes.
15.3. Analysis
Comparison 15 Misoprostol versus vaginal…
15.3. Analysis
Comparison 15 Misoprostol versus vaginal prostaglandin: all women with ruptured membranes and unfavourable…
15.3. Analysis Comparison 15 Misoprostol versus vaginal prostaglandin: all women with ruptured membranes and unfavourable cervix, Outcome 3 Uterine hyperstimulation without FHR changes.
15.4. Analysis
Comparison 15 Misoprostol versus vaginal…
15.4. Analysis
Comparison 15 Misoprostol versus vaginal prostaglandin: all women with ruptured membranes and unfavourable…
15.4. Analysis Comparison 15 Misoprostol versus vaginal prostaglandin: all women with ruptured membranes and unfavourable cervix, Outcome 4 Instrumental vaginal delivery.
15.5. Analysis
Comparison 15 Misoprostol versus vaginal…
15.5. Analysis
Comparison 15 Misoprostol versus vaginal prostaglandin: all women with ruptured membranes and unfavourable…
15.5. Analysis Comparison 15 Misoprostol versus vaginal prostaglandin: all women with ruptured membranes and unfavourable cervix, Outcome 5 Apgar score
15.6. Analysis
Comparison 15 Misoprostol versus vaginal…
15.6. Analysis
Comparison 15 Misoprostol versus vaginal prostaglandin: all women with ruptured membranes and unfavourable…
15.6. Analysis Comparison 15 Misoprostol versus vaginal prostaglandin: all women with ruptured membranes and unfavourable cervix, Outcome 6 Neonatal intensive care unit admission.
15.7. Analysis
Comparison 15 Misoprostol versus vaginal…
15.7. Analysis
Comparison 15 Misoprostol versus vaginal prostaglandin: all women with ruptured membranes and unfavourable…
15.7. Analysis Comparison 15 Misoprostol versus vaginal prostaglandin: all women with ruptured membranes and unfavourable cervix, Outcome 7 Oxytocin augmentation.
16.1. Analysis
Comparison 16 Misoprostol versus vaginal…
16.1. Analysis
Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 1 Vaginal delivery not…
16.1. Analysis Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 1 Vaginal delivery not achieved within 24 hours.
16.2. Analysis
Comparison 16 Misoprostol versus vaginal…
16.2. Analysis
Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 2 Uterine hyperstimulation with…
16.2. Analysis Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 2 Uterine hyperstimulation with FHR changes.
16.3. Analysis
Comparison 16 Misoprostol versus vaginal…
16.3. Analysis
Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 3 Caesarean section.
16.3. Analysis Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 3 Caesarean section.
16.4. Analysis
Comparison 16 Misoprostol versus vaginal…
16.4. Analysis
Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 4 Uterine hyperstimulation without…
16.4. Analysis Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 4 Uterine hyperstimulation without FHR changes.
16.5. Analysis
Comparison 16 Misoprostol versus vaginal…
16.5. Analysis
Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 5 Apgar score
16.5. Analysis Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 5 Apgar score
16.6. Analysis
Comparison 16 Misoprostol versus vaginal…
16.6. Analysis
Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 6 Neonatal intensive care…
16.6. Analysis Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 6 Neonatal intensive care unit admission.
16.7. Analysis
Comparison 16 Misoprostol versus vaginal…
16.7. Analysis
Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 7 Oxytocin augmentation.
16.7. Analysis Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 7 Oxytocin augmentation.
16.8. Analysis
Comparison 16 Misoprostol versus vaginal…
16.8. Analysis
Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 8 Serious neonatal morbidity.
16.8. Analysis Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 8 Serious neonatal morbidity.
16.9. Analysis
Comparison 16 Misoprostol versus vaginal…
16.9. Analysis
Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 9 Perinatal death.
16.9. Analysis Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 9 Perinatal death.
16.10. Analysis
Comparison 16 Misoprostol versus vaginal…
16.10. Analysis
Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 10 Serious maternal morbidity…
16.10. Analysis Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 10 Serious maternal morbidity or death.
16.11. Analysis
Comparison 16 Misoprostol versus vaginal…
16.11. Analysis
Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 11 Instrumental vaginal delivery.
16.11. Analysis Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 11 Instrumental vaginal delivery.
16.12. Analysis
Comparison 16 Misoprostol versus vaginal…
16.12. Analysis
Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 12 Meconium‐stained liquor.
16.12. Analysis Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 12 Meconium‐stained liquor.
16.13. Analysis
Comparison 16 Misoprostol versus vaginal…
16.13. Analysis
Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 13 Uterine rupture.
16.13. Analysis Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 13 Uterine rupture.
16.14. Analysis
Comparison 16 Misoprostol versus vaginal…
16.14. Analysis
Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 14 Postpartum haemorrhage.
16.14. Analysis Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 14 Postpartum haemorrhage.
16.15. Analysis
Comparison 16 Misoprostol versus vaginal…
16.15. Analysis
Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 15 Serious maternal complications.
16.15. Analysis Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 15 Serious maternal complications.
16.16. Analysis
Comparison 16 Misoprostol versus vaginal…
16.16. Analysis
Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 16 Epidural analgesia.
16.16. Analysis Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 16 Epidural analgesia.
16.17. Analysis
Comparison 16 Misoprostol versus vaginal…
16.17. Analysis
Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 17 Maternal side effects…
16.17. Analysis Comparison 16 Misoprostol versus vaginal prostaglandin: all primiparae, Outcome 17 Maternal side effects (eg nausea, vomiting, diarrhoea).
17.1. Analysis
Comparison 17 Misoprostol versus vaginal…
17.1. Analysis
Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 1 Vaginal…
17.1. Analysis Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 1 Vaginal delivery not achieved within 24 hours.
17.2. Analysis
Comparison 17 Misoprostol versus vaginal…
17.2. Analysis
Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 2 Uterine…
17.2. Analysis Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 2 Uterine hyperstimulation with FHR changes.
17.3. Analysis
Comparison 17 Misoprostol versus vaginal…
17.3. Analysis
Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 3 Caesarean…
17.3. Analysis Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 3 Caesarean section.
17.4. Analysis
Comparison 17 Misoprostol versus vaginal…
17.4. Analysis
Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 4 Apgar…
17.4. Analysis Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 4 Apgar score
17.5. Analysis
Comparison 17 Misoprostol versus vaginal…
17.5. Analysis
Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 5 Serious…
17.5. Analysis Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 5 Serious neonatal morbidity.
17.6. Analysis
Comparison 17 Misoprostol versus vaginal…
17.6. Analysis
Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 6 Neonatal…
17.6. Analysis Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 6 Neonatal intensive care admission.
17.7. Analysis
Comparison 17 Misoprostol versus vaginal…
17.7. Analysis
Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 7 Oxytocin…
17.7. Analysis Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 7 Oxytocin augmentation.
17.8. Analysis
Comparison 17 Misoprostol versus vaginal…
17.8. Analysis
Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 8 Perinatal…
17.8. Analysis Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 8 Perinatal death.
17.9. Analysis
Comparison 17 Misoprostol versus vaginal…
17.9. Analysis
Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 9 Serious…
17.9. Analysis Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 9 Serious maternal morbidity or death.
17.10. Analysis
Comparison 17 Misoprostol versus vaginal…
17.10. Analysis
Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 10 Uterine…
17.10. Analysis Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 10 Uterine hyperstimulation without FHR changes.
17.11. Analysis
Comparison 17 Misoprostol versus vaginal…
17.11. Analysis
Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 11 Instrumental…
17.11. Analysis Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 11 Instrumental vaginal delivery.
17.12. Analysis
Comparison 17 Misoprostol versus vaginal…
17.12. Analysis
Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 12 Meconium‐stained…
17.12. Analysis Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 12 Meconium‐stained liquor.
17.13. Analysis
Comparison 17 Misoprostol versus vaginal…
17.13. Analysis
Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 13 Uterine…
17.13. Analysis Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 13 Uterine rupture.
17.14. Analysis
Comparison 17 Misoprostol versus vaginal…
17.14. Analysis
Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 14 Postpartum…
17.14. Analysis Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 14 Postpartum haemorrhage.
17.15. Analysis
Comparison 17 Misoprostol versus vaginal…
17.15. Analysis
Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 15 Serious…
17.15. Analysis Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 15 Serious maternal complications.
17.16. Analysis
Comparison 17 Misoprostol versus vaginal…
17.16. Analysis
Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 16 Epidural…
17.16. Analysis Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 16 Epidural analgesia.
17.17. Analysis
Comparison 17 Misoprostol versus vaginal…
17.17. Analysis
Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 17 Maternal…
17.17. Analysis Comparison 17 Misoprostol versus vaginal prostaglandin: all primiparae, unfavourable cervix, Outcome 17 Maternal side effects (eg nausea, vomiting, diarrhoea).
18.1. Analysis
Comparison 18 Misoprostol versus vaginal…
18.1. Analysis
Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome…
18.1. Analysis Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome 1 Vaginal delivery not achieved within 24 hours.
18.2. Analysis
Comparison 18 Misoprostol versus vaginal…
18.2. Analysis
Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome…
18.2. Analysis Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome 2 Uterine hyperstimulation with FHR changes.
18.3. Analysis
Comparison 18 Misoprostol versus vaginal…
18.3. Analysis
Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome…
18.3. Analysis Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome 3 Caesarean section.
18.4. Analysis
Comparison 18 Misoprostol versus vaginal…
18.4. Analysis
Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome…
18.4. Analysis Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome 4 Uterine hyperstimulation without FHR changes.
18.5. Analysis
Comparison 18 Misoprostol versus vaginal…
18.5. Analysis
Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome…
18.5. Analysis Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome 5 Apgar score
18.6. Analysis
Comparison 18 Misoprostol versus vaginal…
18.6. Analysis
Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome…
18.6. Analysis Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome 6 Neonatal intensive care unit admission.
18.7. Analysis
Comparison 18 Misoprostol versus vaginal…
18.7. Analysis
Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome…
18.7. Analysis Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome 7 Oxytocin augmentation.
18.8. Analysis
Comparison 18 Misoprostol versus vaginal…
18.8. Analysis
Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome…
18.8. Analysis Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome 8 Postpartum haemorrhage.
18.9. Analysis
Comparison 18 Misoprostol versus vaginal…
18.9. Analysis
Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome…
18.9. Analysis Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome 9 Serious maternal complication.
18.10. Analysis
Comparison 18 Misoprostol versus vaginal…
18.10. Analysis
Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome…
18.10. Analysis Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome 10 Epidural analgesia.
18.11. Analysis
Comparison 18 Misoprostol versus vaginal…
18.11. Analysis
Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome…
18.11. Analysis Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome 11 Meconium‐stained liquor.
18.12. Analysis
Comparison 18 Misoprostol versus vaginal…
18.12. Analysis
Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome…
18.12. Analysis Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome 12 Serious maternal morbidity or death.
18.13. Analysis
Comparison 18 Misoprostol versus vaginal…
18.13. Analysis
Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome…
18.13. Analysis Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome 13 Serious neonatal morbidity.
18.14. Analysis
Comparison 18 Misoprostol versus vaginal…
18.14. Analysis
Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome…
18.14. Analysis Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome 14 Perinatal death.
18.15. Analysis
Comparison 18 Misoprostol versus vaginal…
18.15. Analysis
Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome…
18.15. Analysis Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome 15 Uterine rupture.
18.16. Analysis
Comparison 18 Misoprostol versus vaginal…
18.16. Analysis
Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome…
18.16. Analysis Comparison 18 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, unfavourable cervix, Outcome 16 Maternal side effects (eg nausea, vomiting, diarrhoea).
19.1. Analysis
Comparison 19 Misoprostol versus vaginal…
19.1. Analysis
Comparison 19 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, variable or undefined…
19.1. Analysis Comparison 19 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, variable or undefined cervix, Outcome 1 Uterine hyperstimulation with FHR changes.
19.2. Analysis
Comparison 19 Misoprostol versus vaginal…
19.2. Analysis
Comparison 19 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, variable or undefined…
19.2. Analysis Comparison 19 Misoprostol versus vaginal prostaglandin: all primiparae, intact membranes, variable or undefined cervix, Outcome 2 Caesarean section.
20.1. Analysis
Comparison 20 Misoprostol versus vaginal…
20.1. Analysis
Comparison 20 Misoprostol versus vaginal prostaglandin: all primiparae with ruptured membranes and unfavourable…
20.1. Analysis Comparison 20 Misoprostol versus vaginal prostaglandin: all primiparae with ruptured membranes and unfavourable cervix, Outcome 1 Oxytocin augmentation.
20.2. Analysis
Comparison 20 Misoprostol versus vaginal…
20.2. Analysis
Comparison 20 Misoprostol versus vaginal prostaglandin: all primiparae with ruptured membranes and unfavourable…
20.2. Analysis Comparison 20 Misoprostol versus vaginal prostaglandin: all primiparae with ruptured membranes and unfavourable cervix, Outcome 2 Instrumental vaginal delivery.
21.1. Analysis
Comparison 21 Misoprostol versus vaginal…
21.1. Analysis
Comparison 21 Misoprostol versus vaginal prostaglandin: all multiparae, Outcome 1 Vaginal delivery not…
21.1. Analysis Comparison 21 Misoprostol versus vaginal prostaglandin: all multiparae, Outcome 1 Vaginal delivery not achieved within 24 hours.
21.2. Analysis
Comparison 21 Misoprostol versus vaginal…
21.2. Analysis
Comparison 21 Misoprostol versus vaginal prostaglandin: all multiparae, Outcome 2 Uterine hyperstimulation with…
21.2. Analysis Comparison 21 Misoprostol versus vaginal prostaglandin: all multiparae, Outcome 2 Uterine hyperstimulation with FHR changes.
21.3. Analysis
Comparison 21 Misoprostol versus vaginal…
21.3. Analysis
Comparison 21 Misoprostol versus vaginal prostaglandin: all multiparae, Outcome 3 Caesarean section.
21.3. Analysis Comparison 21 Misoprostol versus vaginal prostaglandin: all multiparae, Outcome 3 Caesarean section.
21.4. Analysis
Comparison 21 Misoprostol versus vaginal…
21.4. Analysis
Comparison 21 Misoprostol versus vaginal prostaglandin: all multiparae, Outcome 4 Oxytocin augmentation.
21.4. Analysis Comparison 21 Misoprostol versus vaginal prostaglandin: all multiparae, Outcome 4 Oxytocin augmentation.
21.5. Analysis
Comparison 21 Misoprostol versus vaginal…
21.5. Analysis
Comparison 21 Misoprostol versus vaginal prostaglandin: all multiparae, Outcome 5 Uterine hyperstimulation without…
21.5. Analysis Comparison 21 Misoprostol versus vaginal prostaglandin: all multiparae, Outcome 5 Uterine hyperstimulation without FHR changes.
21.6. Analysis
Comparison 21 Misoprostol versus vaginal…
21.6. Analysis
Comparison 21 Misoprostol versus vaginal prostaglandin: all multiparae, Outcome 6 Instrumental delivery.
21.6. Analysis Comparison 21 Misoprostol versus vaginal prostaglandin: all multiparae, Outcome 6 Instrumental delivery.
21.7. Analysis
Comparison 21 Misoprostol versus vaginal…
21.7. Analysis
Comparison 21 Misoprostol versus vaginal prostaglandin: all multiparae, Outcome 7 Apgar score
21.7. Analysis Comparison 21 Misoprostol versus vaginal prostaglandin: all multiparae, Outcome 7 Apgar score
21.8. Analysis
Comparison 21 Misoprostol versus vaginal…
21.8. Analysis
Comparison 21 Misoprostol versus vaginal prostaglandin: all multiparae, Outcome 8 Neonatal intensive care…
21.8. Analysis Comparison 21 Misoprostol versus vaginal prostaglandin: all multiparae, Outcome 8 Neonatal intensive care unit admission.
22.1. Analysis
Comparison 22 Misoprostol versus vaginal…
22.1. Analysis
Comparison 22 Misoprostol versus vaginal prostaglandin: all multiparae, unfavourable cervix, Outcome 1 Vaginal…
22.1. Analysis Comparison 22 Misoprostol versus vaginal prostaglandin: all multiparae, unfavourable cervix, Outcome 1 Vaginal delivery not achieved within 24 hours.
22.2. Analysis
Comparison 22 Misoprostol versus vaginal…
22.2. Analysis
Comparison 22 Misoprostol versus vaginal prostaglandin: all multiparae, unfavourable cervix, Outcome 2 Caesarean…
22.2. Analysis Comparison 22 Misoprostol versus vaginal prostaglandin: all multiparae, unfavourable cervix, Outcome 2 Caesarean section.
22.3. Analysis
Comparison 22 Misoprostol versus vaginal…
22.3. Analysis
Comparison 22 Misoprostol versus vaginal prostaglandin: all multiparae, unfavourable cervix, Outcome 3 Apgar…
22.3. Analysis Comparison 22 Misoprostol versus vaginal prostaglandin: all multiparae, unfavourable cervix, Outcome 3 Apgar score
22.4. Analysis
Comparison 22 Misoprostol versus vaginal…
22.4. Analysis
Comparison 22 Misoprostol versus vaginal prostaglandin: all multiparae, unfavourable cervix, Outcome 4 Neonatal…
22.4. Analysis Comparison 22 Misoprostol versus vaginal prostaglandin: all multiparae, unfavourable cervix, Outcome 4 Neonatal intensive care unit admission.
22.5. Analysis
Comparison 22 Misoprostol versus vaginal…
22.5. Analysis
Comparison 22 Misoprostol versus vaginal prostaglandin: all multiparae, unfavourable cervix, Outcome 5 Oxytocin…
22.5. Analysis Comparison 22 Misoprostol versus vaginal prostaglandin: all multiparae, unfavourable cervix, Outcome 5 Oxytocin augmentation.
23.1. Analysis
Comparison 23 Misoprostol versus vaginal…
23.1. Analysis
Comparison 23 Misoprostol versus vaginal prostaglandin: all multiparae, intact membranes, unfavourable cervix, Outcome…
23.1. Analysis Comparison 23 Misoprostol versus vaginal prostaglandin: all multiparae, intact membranes, unfavourable cervix, Outcome 1 Vaginal delivery not achieved in 24 hours.
23.2. Analysis
Comparison 23 Misoprostol versus vaginal…
23.2. Analysis
Comparison 23 Misoprostol versus vaginal prostaglandin: all multiparae, intact membranes, unfavourable cervix, Outcome…
23.2. Analysis Comparison 23 Misoprostol versus vaginal prostaglandin: all multiparae, intact membranes, unfavourable cervix, Outcome 2 Instrumental vaginal delivery.
24.1. Analysis
Comparison 24 Misoprostol versus vaginal…
24.1. Analysis
Comparison 24 Misoprostol versus vaginal prostaglandin: all multiparae, intact membranes, variable or undefined…
24.1. Analysis Comparison 24 Misoprostol versus vaginal prostaglandin: all multiparae, intact membranes, variable or undefined cervix, Outcome 1 Uterine hyperstimulation with FHR changes.
24.2. Analysis
Comparison 24 Misoprostol versus vaginal…
24.2. Analysis
Comparison 24 Misoprostol versus vaginal prostaglandin: all multiparae, intact membranes, variable or undefined…
24.2. Analysis Comparison 24 Misoprostol versus vaginal prostaglandin: all multiparae, intact membranes, variable or undefined cervix, Outcome 2 Caesarean section.
24.3. Analysis
Comparison 24 Misoprostol versus vaginal…
24.3. Analysis
Comparison 24 Misoprostol versus vaginal prostaglandin: all multiparae, intact membranes, variable or undefined…
24.3. Analysis Comparison 24 Misoprostol versus vaginal prostaglandin: all multiparae, intact membranes, variable or undefined cervix, Outcome 3 Caesarean section.
25.1. Analysis
Comparison 25 Misoprostol versus intracervical…
25.1. Analysis
Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 1 Vaginal delivery not…
25.1. Analysis Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 1 Vaginal delivery not achieved within 24 hours.
25.2. Analysis
Comparison 25 Misoprostol versus intracervical…
25.2. Analysis
Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 2 Uterine hyperstimulation with…
25.2. Analysis Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 2 Uterine hyperstimulation with FHR changes.
25.3. Analysis
Comparison 25 Misoprostol versus intracervical…
25.3. Analysis
Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 3 Caesarean section.
25.3. Analysis Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 3 Caesarean section.
25.4. Analysis
Comparison 25 Misoprostol versus intracervical…
25.4. Analysis
Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 4 Serious neonatal morbidity/perinatal…
25.4. Analysis Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 4 Serious neonatal morbidity/perinatal death.
25.5. Analysis
Comparison 25 Misoprostol versus intracervical…
25.5. Analysis
Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 5 Cervix unfavourable/unchanged after…
25.5. Analysis Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours.
25.6. Analysis
Comparison 25 Misoprostol versus intracervical…
25.6. Analysis
Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 6 Oxytocin augmentation.
25.6. Analysis Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 6 Oxytocin augmentation.
25.7. Analysis
Comparison 25 Misoprostol versus intracervical…
25.7. Analysis
Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 7 Uterine hyperstimulation without…
25.7. Analysis Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 7 Uterine hyperstimulation without FHR changes.
25.8. Analysis
Comparison 25 Misoprostol versus intracervical…
25.8. Analysis
Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 8 Uterine rupture.
25.8. Analysis Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 8 Uterine rupture.
25.9. Analysis
Comparison 25 Misoprostol versus intracervical…
25.9. Analysis
Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 9 Epidural analgesia.
25.9. Analysis Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 9 Epidural analgesia.
25.10. Analysis
Comparison 25 Misoprostol versus intracervical…
25.10. Analysis
Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 10 Instrumental vaginal delivery.
25.10. Analysis Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 10 Instrumental vaginal delivery.
25.11. Analysis
Comparison 25 Misoprostol versus intracervical…
25.11. Analysis
Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 11 Meconium‐stained liquor.
25.11. Analysis Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 11 Meconium‐stained liquor.
25.12. Analysis
Comparison 25 Misoprostol versus intracervical…
25.12. Analysis
Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 12 Apgar score
25.12. Analysis Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 12 Apgar score
25.13. Analysis
Comparison 25 Misoprostol versus intracervical…
25.13. Analysis
Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 13 Neonatal intensive care…
25.13. Analysis Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 13 Neonatal intensive care unit admission.
25.14. Analysis
Comparison 25 Misoprostol versus intracervical…
25.14. Analysis
Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 14 Perinatal death.
25.14. Analysis Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 14 Perinatal death.
25.15. Analysis
Comparison 25 Misoprostol versus intracervical…
25.15. Analysis
Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 15 Maternal side effects…
25.15. Analysis Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 15 Maternal side effects (eg nausea, vomiting, diarrhoea).
25.16. Analysis
Comparison 25 Misoprostol versus intracervical…
25.16. Analysis
Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 16 Postpartum haemorrhage.
25.16. Analysis Comparison 25 Misoprostol versus intracervical prostaglandin: all women, Outcome 16 Postpartum haemorrhage.
26.1. Analysis
Comparison 26 Misoprostol versus intracervical…
26.1. Analysis
Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 1…
26.1. Analysis Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 1 Vaginal delivery not achieved within 24 hours.
26.2. Analysis
Comparison 26 Misoprostol versus intracervical…
26.2. Analysis
Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 2…
26.2. Analysis Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 2 Uterine hyperstimulation with FHR changes.
26.3. Analysis
Comparison 26 Misoprostol versus intracervical…
26.3. Analysis
Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 3…
26.3. Analysis Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 3 Caesarean section.
26.4. Analysis
Comparison 26 Misoprostol versus intracervical…
26.4. Analysis
Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 4…
26.4. Analysis Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 4 Serious neonatal morbidity.
26.5. Analysis
Comparison 26 Misoprostol versus intracervical…
26.5. Analysis
Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 5…
26.5. Analysis Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours.
26.6. Analysis
Comparison 26 Misoprostol versus intracervical…
26.6. Analysis
Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 6…
26.6. Analysis Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 6 Oxytocin augmentation.
26.7. Analysis
Comparison 26 Misoprostol versus intracervical…
26.7. Analysis
Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 7…
26.7. Analysis Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 7 Uterine hyperstimulation without FHR changes.
26.8. Analysis
Comparison 26 Misoprostol versus intracervical…
26.8. Analysis
Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 8…
26.8. Analysis Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 8 Uterine rupture.
26.9. Analysis
Comparison 26 Misoprostol versus intracervical…
26.9. Analysis
Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 9…
26.9. Analysis Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 9 Epidural analgesia.
26.10. Analysis
Comparison 26 Misoprostol versus intracervical…
26.10. Analysis
Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 10…
26.10. Analysis Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 10 Instrumental vaginal delivery.
26.11. Analysis
Comparison 26 Misoprostol versus intracervical…
26.11. Analysis
Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 11…
26.11. Analysis Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 11 Meconium‐stained liquor.
26.12. Analysis
Comparison 26 Misoprostol versus intracervical…
26.12. Analysis
Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 12…
26.12. Analysis Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 12 Apgar score
26.13. Analysis
Comparison 26 Misoprostol versus intracervical…
26.13. Analysis
Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 13…
26.13. Analysis Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 13 Neonatal intensive care unit admission.
26.14. Analysis
Comparison 26 Misoprostol versus intracervical…
26.14. Analysis
Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 14…
26.14. Analysis Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 14 Perinatal death.
26.15. Analysis
Comparison 26 Misoprostol versus intracervical…
26.15. Analysis
Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 15…
26.15. Analysis Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 15 Maternal side effects (eg nausea, vomiting, diarrhoea).
26.16. Analysis
Comparison 26 Misoprostol versus intracervical…
26.16. Analysis
Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 16…
26.16. Analysis Comparison 26 Misoprostol versus intracervical prostaglandin: all women with unfavourable cervix, Outcome 16 Postpartum haemorrhage.
27.1. Analysis
Comparison 27 Misoprostol versus intracervical…
27.1. Analysis
Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable…
27.1. Analysis Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable cervix, Outcome 1 Vaginal delivery not achieved within 24 hours.
27.2. Analysis
Comparison 27 Misoprostol versus intracervical…
27.2. Analysis
Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable…
27.2. Analysis Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable cervix, Outcome 2 Uterine hyperstimulation with FHR changes.
27.3. Analysis
Comparison 27 Misoprostol versus intracervical…
27.3. Analysis
Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable…
27.3. Analysis Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable cervix, Outcome 3 Caesarean section.
27.4. Analysis
Comparison 27 Misoprostol versus intracervical…
27.4. Analysis
Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable…
27.4. Analysis Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable cervix, Outcome 4 Maternal side effects.
27.5. Analysis
Comparison 27 Misoprostol versus intracervical…
27.5. Analysis
Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable…
27.5. Analysis Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable cervix, Outcome 5 Serious neonatal morbidity.
27.6. Analysis
Comparison 27 Misoprostol versus intracervical…
27.6. Analysis
Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable…
27.6. Analysis Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable cervix, Outcome 6 Cervix unfavourable/unchanged after 12‐24 hours.
27.7. Analysis
Comparison 27 Misoprostol versus intracervical…
27.7. Analysis
Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable…
27.7. Analysis Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable cervix, Outcome 7 Oxytocin augmentation.
27.8. Analysis
Comparison 27 Misoprostol versus intracervical…
27.8. Analysis
Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable…
27.8. Analysis Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable cervix, Outcome 8 Uterine hyperstimulation without FHR changes.
27.9. Analysis
Comparison 27 Misoprostol versus intracervical…
27.9. Analysis
Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable…
27.9. Analysis Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable cervix, Outcome 9 Instrumental vaginal delivery.
27.10. Analysis
Comparison 27 Misoprostol versus intracervical…
27.10. Analysis
Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable…
27.10. Analysis Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable cervix, Outcome 10 Meconium‐stained liquor.
27.11. Analysis
Comparison 27 Misoprostol versus intracervical…
27.11. Analysis
Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable…
27.11. Analysis Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable cervix, Outcome 11 Apgar score
27.12. Analysis
Comparison 27 Misoprostol versus intracervical…
27.12. Analysis
Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable…
27.12. Analysis Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable cervix, Outcome 12 Neonatal intensive care unit admission.
27.13. Analysis
Comparison 27 Misoprostol versus intracervical…
27.13. Analysis
Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable…
27.13. Analysis Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable cervix, Outcome 13 Perinatal death.
27.14. Analysis
Comparison 27 Misoprostol versus intracervical…
27.14. Analysis
Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable…
27.14. Analysis Comparison 27 Misoprostol versus intracervical prostaglandin: all women with intact membranes and unfavourable cervix, Outcome 14 Postpartum haemorrhage.
28.1. Analysis
Comparison 28 Misoprostol versus intracervical…
28.1. Analysis
Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable…
28.1. Analysis Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable or undefined cervix, Outcome 1 Vaginal delivery not achieved in 24 hours.
28.2. Analysis
Comparison 28 Misoprostol versus intracervical…
28.2. Analysis
Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable…
28.2. Analysis Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable or undefined cervix, Outcome 2 Uterine hyperstimulation with FHR changes.
28.3. Analysis
Comparison 28 Misoprostol versus intracervical…
28.3. Analysis
Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable…
28.3. Analysis Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable or undefined cervix, Outcome 3 Caesarean section.
28.4. Analysis
Comparison 28 Misoprostol versus intracervical…
28.4. Analysis
Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable…
28.4. Analysis Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable or undefined cervix, Outcome 4 Serious neonatal morbidity/perinatal death.
28.5. Analysis
Comparison 28 Misoprostol versus intracervical…
28.5. Analysis
Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable…
28.5. Analysis Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable or undefined cervix, Outcome 5 Neonatal intensive care unit admission.
28.6. Analysis
Comparison 28 Misoprostol versus intracervical…
28.6. Analysis
Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable…
28.6. Analysis Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable or undefined cervix, Outcome 6 Oxytocin augmentation.
28.7. Analysis
Comparison 28 Misoprostol versus intracervical…
28.7. Analysis
Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable…
28.7. Analysis Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable or undefined cervix, Outcome 7 Epidural analgesia.
28.8. Analysis
Comparison 28 Misoprostol versus intracervical…
28.8. Analysis
Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable…
28.8. Analysis Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable or undefined cervix, Outcome 8 Instrumental vaginal delivery.
28.9. Analysis
Comparison 28 Misoprostol versus intracervical…
28.9. Analysis
Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable…
28.9. Analysis Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable or undefined cervix, Outcome 9 Meconium‐stained liquor.
28.10. Analysis
Comparison 28 Misoprostol versus intracervical…
28.10. Analysis
Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable…
28.10. Analysis Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable or undefined cervix, Outcome 10 Apgar score
28.11. Analysis
Comparison 28 Misoprostol versus intracervical…
28.11. Analysis
Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable…
28.11. Analysis Comparison 28 Misoprostol versus intracervical prostaglandin: all women with intact membranes and variable or undefined cervix, Outcome 11 Perinatal death.
29.1. Analysis
Comparison 29 Misoprostol versus oxytocin:…
29.1. Analysis
Comparison 29 Misoprostol versus oxytocin: all women, Outcome 1 Vaginal delivery not achieved…
29.1. Analysis Comparison 29 Misoprostol versus oxytocin: all women, Outcome 1 Vaginal delivery not achieved within 24 hours.
29.2. Analysis
Comparison 29 Misoprostol versus oxytocin:…
29.2. Analysis
Comparison 29 Misoprostol versus oxytocin: all women, Outcome 2 Uterine hyperstimulation with FHR…
29.2. Analysis Comparison 29 Misoprostol versus oxytocin: all women, Outcome 2 Uterine hyperstimulation with FHR changes.
29.3. Analysis
Comparison 29 Misoprostol versus oxytocin:…
29.3. Analysis
Comparison 29 Misoprostol versus oxytocin: all women, Outcome 3 Caesarean section.
29.3. Analysis Comparison 29 Misoprostol versus oxytocin: all women, Outcome 3 Caesarean section.
29.4. Analysis
Comparison 29 Misoprostol versus oxytocin:…
29.4. Analysis
Comparison 29 Misoprostol versus oxytocin: all women, Outcome 4 Serious neonatal morbidity.
29.4. Analysis Comparison 29 Misoprostol versus oxytocin: all women, Outcome 4 Serious neonatal morbidity.
29.5. Analysis
Comparison 29 Misoprostol versus oxytocin:…
29.5. Analysis
Comparison 29 Misoprostol versus oxytocin: all women, Outcome 5 Serious maternal morbidity or…
29.5. Analysis Comparison 29 Misoprostol versus oxytocin: all women, Outcome 5 Serious maternal morbidity or death.
29.6. Analysis
Comparison 29 Misoprostol versus oxytocin:…
29.6. Analysis
Comparison 29 Misoprostol versus oxytocin: all women, Outcome 6 Maternal side effects (eg…
29.6. Analysis Comparison 29 Misoprostol versus oxytocin: all women, Outcome 6 Maternal side effects (eg nausea, vomiting, diarrhoea).
29.7. Analysis
Comparison 29 Misoprostol versus oxytocin:…
29.7. Analysis
Comparison 29 Misoprostol versus oxytocin: all women, Outcome 7 Oxytocin augmentation.
29.7. Analysis Comparison 29 Misoprostol versus oxytocin: all women, Outcome 7 Oxytocin augmentation.
29.8. Analysis
Comparison 29 Misoprostol versus oxytocin:…
29.8. Analysis
Comparison 29 Misoprostol versus oxytocin: all women, Outcome 8 Uterine hyperstimulation without FHR…
29.8. Analysis Comparison 29 Misoprostol versus oxytocin: all women, Outcome 8 Uterine hyperstimulation without FHR changes.
29.9. Analysis
Comparison 29 Misoprostol versus oxytocin:…
29.9. Analysis
Comparison 29 Misoprostol versus oxytocin: all women, Outcome 9 Uterine rupture.
29.9. Analysis Comparison 29 Misoprostol versus oxytocin: all women, Outcome 9 Uterine rupture.
29.10. Analysis
Comparison 29 Misoprostol versus oxytocin:…
29.10. Analysis
Comparison 29 Misoprostol versus oxytocin: all women, Outcome 10 Epidural analgesia.
29.10. Analysis Comparison 29 Misoprostol versus oxytocin: all women, Outcome 10 Epidural analgesia.
29.11. Analysis
Comparison 29 Misoprostol versus oxytocin:…
29.11. Analysis
Comparison 29 Misoprostol versus oxytocin: all women, Outcome 11 Instrumental vaginal delivery.
29.11. Analysis Comparison 29 Misoprostol versus oxytocin: all women, Outcome 11 Instrumental vaginal delivery.
29.12. Analysis
Comparison 29 Misoprostol versus oxytocin:…
29.12. Analysis
Comparison 29 Misoprostol versus oxytocin: all women, Outcome 12 Meconium‐stained liquor.
29.12. Analysis Comparison 29 Misoprostol versus oxytocin: all women, Outcome 12 Meconium‐stained liquor.
29.13. Analysis
Comparison 29 Misoprostol versus oxytocin:…
29.13. Analysis
Comparison 29 Misoprostol versus oxytocin: all women, Outcome 13 Apgar score
29.13. Analysis Comparison 29 Misoprostol versus oxytocin: all women, Outcome 13 Apgar score
29.14. Analysis
Comparison 29 Misoprostol versus oxytocin:…
29.14. Analysis
Comparison 29 Misoprostol versus oxytocin: all women, Outcome 14 Neonatal intensive care unit…
29.14. Analysis Comparison 29 Misoprostol versus oxytocin: all women, Outcome 14 Neonatal intensive care unit admission.
29.15. Analysis
Comparison 29 Misoprostol versus oxytocin:…
29.15. Analysis
Comparison 29 Misoprostol versus oxytocin: all women, Outcome 15 Serious maternal complications.
29.15. Analysis Comparison 29 Misoprostol versus oxytocin: all women, Outcome 15 Serious maternal complications.
29.16. Analysis
Comparison 29 Misoprostol versus oxytocin:…
29.16. Analysis
Comparison 29 Misoprostol versus oxytocin: all women, Outcome 16 Perinatal death.
29.16. Analysis Comparison 29 Misoprostol versus oxytocin: all women, Outcome 16 Perinatal death.
29.17. Analysis
Comparison 29 Misoprostol versus oxytocin:…
29.17. Analysis
Comparison 29 Misoprostol versus oxytocin: all women, Outcome 17 Postpartum haemorrhage.
29.17. Analysis Comparison 29 Misoprostol versus oxytocin: all women, Outcome 17 Postpartum haemorrhage.
30.1. Analysis
Comparison 30 Misoprostol versus oxytocin:…
30.1. Analysis
Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 1 Vaginal…
30.1. Analysis Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 1 Vaginal delivery not achieved within 24 hours.
30.2. Analysis
Comparison 30 Misoprostol versus oxytocin:…
30.2. Analysis
Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 2 Uterine…
30.2. Analysis Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 2 Uterine hyperstimulation with FHR changes.
30.3. Analysis
Comparison 30 Misoprostol versus oxytocin:…
30.3. Analysis
Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 3 Caesarean…
30.3. Analysis Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 3 Caesarean section.
30.4. Analysis
Comparison 30 Misoprostol versus oxytocin:…
30.4. Analysis
Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 4 Perinatal…
30.4. Analysis Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 4 Perinatal death.
30.5. Analysis
Comparison 30 Misoprostol versus oxytocin:…
30.5. Analysis
Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 5 Serious…
30.5. Analysis Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 5 Serious maternal morbidity or death.
30.6. Analysis
Comparison 30 Misoprostol versus oxytocin:…
30.6. Analysis
Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 6 Maternal…
30.6. Analysis Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 6 Maternal side effects.
30.7. Analysis
Comparison 30 Misoprostol versus oxytocin:…
30.7. Analysis
Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 7 Postpartum…
30.7. Analysis Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 7 Postpartum haemorrhage.
30.8. Analysis
Comparison 30 Misoprostol versus oxytocin:…
30.8. Analysis
Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 8 Uterine…
30.8. Analysis Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 8 Uterine hyperstimulation without FHR changes.
30.9. Analysis
Comparison 30 Misoprostol versus oxytocin:…
30.9. Analysis
Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 9 Uterine…
30.9. Analysis Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 9 Uterine rupture.
30.10. Analysis
Comparison 30 Misoprostol versus oxytocin:…
30.10. Analysis
Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 10 Serious…
30.10. Analysis Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 10 Serious maternal complications.
30.11. Analysis
Comparison 30 Misoprostol versus oxytocin:…
30.11. Analysis
Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 11 Instrumental…
30.11. Analysis Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 11 Instrumental vaginal delivery.
30.12. Analysis
Comparison 30 Misoprostol versus oxytocin:…
30.12. Analysis
Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 12 Meconium‐stained…
30.12. Analysis Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 12 Meconium‐stained liquor.
30.13. Analysis
Comparison 30 Misoprostol versus oxytocin:…
30.13. Analysis
Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 13 Apgar…
30.13. Analysis Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 13 Apgar score
30.14. Analysis
Comparison 30 Misoprostol versus oxytocin:…
30.14. Analysis
Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 14 Neonatal…
30.14. Analysis Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 14 Neonatal intensive care unit admission.
30.15. Analysis
Comparison 30 Misoprostol versus oxytocin:…
30.15. Analysis
Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 15 Serious…
30.15. Analysis Comparison 30 Misoprostol versus oxytocin: all women with unfavourable cervix, Outcome 15 Serious neonatal morbidity.
31.1. Analysis
Comparison 31 Misoprostol versus oxytocin:…
31.1. Analysis
Comparison 31 Misoprostol versus oxytocin: all women with intact membranes and unfavourable cervix,…
31.1. Analysis Comparison 31 Misoprostol versus oxytocin: all women with intact membranes and unfavourable cervix, Outcome 1 Instrumental delivery.
31.2. Analysis
Comparison 31 Misoprostol versus oxytocin:…
31.2. Analysis
Comparison 31 Misoprostol versus oxytocin: all women with intact membranes and unfavourable cervix,…
31.2. Analysis Comparison 31 Misoprostol versus oxytocin: all women with intact membranes and unfavourable cervix, Outcome 2 Vaginal delivery not achieved in 24 hours.
31.3. Analysis
Comparison 31 Misoprostol versus oxytocin:…
31.3. Analysis
Comparison 31 Misoprostol versus oxytocin: all women with intact membranes and unfavourable cervix,…
31.3. Analysis Comparison 31 Misoprostol versus oxytocin: all women with intact membranes and unfavourable cervix, Outcome 3 Caesarean section.
31.4. Analysis
Comparison 31 Misoprostol versus oxytocin:…
31.4. Analysis
Comparison 31 Misoprostol versus oxytocin: all women with intact membranes and unfavourable cervix,…
31.4. Analysis Comparison 31 Misoprostol versus oxytocin: all women with intact membranes and unfavourable cervix, Outcome 4 Uterine hyperstimulation with FHR changes.
31.5. Analysis
Comparison 31 Misoprostol versus oxytocin:…
31.5. Analysis
Comparison 31 Misoprostol versus oxytocin: all women with intact membranes and unfavourable cervix,…
31.5. Analysis Comparison 31 Misoprostol versus oxytocin: all women with intact membranes and unfavourable cervix, Outcome 5 Uterine hyperstimulation without FHR changes.
31.6. Analysis
Comparison 31 Misoprostol versus oxytocin:…
31.6. Analysis
Comparison 31 Misoprostol versus oxytocin: all women with intact membranes and unfavourable cervix,…
31.6. Analysis Comparison 31 Misoprostol versus oxytocin: all women with intact membranes and unfavourable cervix, Outcome 6 Meconium‐stained liquor.
31.7. Analysis
Comparison 31 Misoprostol versus oxytocin:…
31.7. Analysis
Comparison 31 Misoprostol versus oxytocin: all women with intact membranes and unfavourable cervix,…
31.7. Analysis Comparison 31 Misoprostol versus oxytocin: all women with intact membranes and unfavourable cervix, Outcome 7 Serious neonatal morbidity.
31.8. Analysis
Comparison 31 Misoprostol versus oxytocin:…
31.8. Analysis
Comparison 31 Misoprostol versus oxytocin: all women with intact membranes and unfavourable cervix,…
31.8. Analysis Comparison 31 Misoprostol versus oxytocin: all women with intact membranes and unfavourable cervix, Outcome 8 Apgar score
32.1. Analysis
Comparison 32 Misoprostol versus oxytocin:…
32.1. Analysis
Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or…
32.1. Analysis Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or undefined cervix, Outcome 1 Vaginal delivery not achieved within 24 hours.
32.2. Analysis
Comparison 32 Misoprostol versus oxytocin:…
32.2. Analysis
Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or…
32.2. Analysis Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or undefined cervix, Outcome 2 Uterine hyperstimulation with FHR changes.
32.3. Analysis
Comparison 32 Misoprostol versus oxytocin:…
32.3. Analysis
Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or…
32.3. Analysis Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or undefined cervix, Outcome 3 Caesarean section.
32.4. Analysis
Comparison 32 Misoprostol versus oxytocin:…
32.4. Analysis
Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or…
32.4. Analysis Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or undefined cervix, Outcome 4 Serious maternal morbidity or death.
32.5. Analysis
Comparison 32 Misoprostol versus oxytocin:…
32.5. Analysis
Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or…
32.5. Analysis Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or undefined cervix, Outcome 5 Uterine hyperstimulation without FHR changes.
32.6. Analysis
Comparison 32 Misoprostol versus oxytocin:…
32.6. Analysis
Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or…
32.6. Analysis Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or undefined cervix, Outcome 6 Epidural analgesia.
32.7. Analysis
Comparison 32 Misoprostol versus oxytocin:…
32.7. Analysis
Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or…
32.7. Analysis Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or undefined cervix, Outcome 7 Instrumental vaginal delivery.
32.8. Analysis
Comparison 32 Misoprostol versus oxytocin:…
32.8. Analysis
Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or…
32.8. Analysis Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or undefined cervix, Outcome 8 Meconium‐stained liquor.
32.9. Analysis
Comparison 32 Misoprostol versus oxytocin:…
32.9. Analysis
Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or…
32.9. Analysis Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or undefined cervix, Outcome 9 Apgar score
32.10. Analysis
Comparison 32 Misoprostol versus oxytocin:…
32.10. Analysis
Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or…
32.10. Analysis Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or undefined cervix, Outcome 10 Neonatal intensive care unit admission.
32.11. Analysis
Comparison 32 Misoprostol versus oxytocin:…
32.11. Analysis
Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or…
32.11. Analysis Comparison 32 Misoprostol versus oxytocin: all women with intact membranes and variable or undefined cervix, Outcome 11 Perinatal death.
33.1. Analysis
Comparison 33 Misoprostol versus oxytocin:…
33.1. Analysis
Comparison 33 Misoprostol versus oxytocin: all women with ruptured membranes and unfavourable cervix,…
33.1. Analysis Comparison 33 Misoprostol versus oxytocin: all women with ruptured membranes and unfavourable cervix, Outcome 1 Vaginal delivery not achieved in 24 hours.
33.2. Analysis
Comparison 33 Misoprostol versus oxytocin:…
33.2. Analysis
Comparison 33 Misoprostol versus oxytocin: all women with ruptured membranes and unfavourable cervix,…
33.2. Analysis Comparison 33 Misoprostol versus oxytocin: all women with ruptured membranes and unfavourable cervix, Outcome 2 Uterine hyperstimulation without FHR changes.
33.3. Analysis
Comparison 33 Misoprostol versus oxytocin:…
33.3. Analysis
Comparison 33 Misoprostol versus oxytocin: all women with ruptured membranes and unfavourable cervix,…
33.3. Analysis Comparison 33 Misoprostol versus oxytocin: all women with ruptured membranes and unfavourable cervix, Outcome 3 Caesarean section.
33.4. Analysis
Comparison 33 Misoprostol versus oxytocin:…
33.4. Analysis
Comparison 33 Misoprostol versus oxytocin: all women with ruptured membranes and unfavourable cervix,…
33.4. Analysis Comparison 33 Misoprostol versus oxytocin: all women with ruptured membranes and unfavourable cervix, Outcome 4 Maternal side effects.
34.1. Analysis
Comparison 34 Misoprostol versus oxytocin:…
34.1. Analysis
Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or…
34.1. Analysis Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or undefined cervix, Outcome 1 Uterine hyperstimulation with FHR changes.
34.2. Analysis
Comparison 34 Misoprostol versus oxytocin:…
34.2. Analysis
Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or…
34.2. Analysis Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or undefined cervix, Outcome 2 Caesarean section.
34.3. Analysis
Comparison 34 Misoprostol versus oxytocin:…
34.3. Analysis
Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or…
34.3. Analysis Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or undefined cervix, Outcome 3 Oxytocin augmentation.
34.4. Analysis
Comparison 34 Misoprostol versus oxytocin:…
34.4. Analysis
Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or…
34.4. Analysis Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or undefined cervix, Outcome 4 Uterine hyperstimulation without FHR changes.
34.5. Analysis
Comparison 34 Misoprostol versus oxytocin:…
34.5. Analysis
Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or…
34.5. Analysis Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or undefined cervix, Outcome 5 Epidural analgesia.
34.6. Analysis
Comparison 34 Misoprostol versus oxytocin:…
34.6. Analysis
Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or…
34.6. Analysis Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or undefined cervix, Outcome 6 Instrumental vaginal delivery.
34.7. Analysis
Comparison 34 Misoprostol versus oxytocin:…
34.7. Analysis
Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or…
34.7. Analysis Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or undefined cervix, Outcome 7 Meconium‐stained liquor.
34.8. Analysis
Comparison 34 Misoprostol versus oxytocin:…
34.8. Analysis
Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or…
34.8. Analysis Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or undefined cervix, Outcome 8 Apgar score
34.9. Analysis
Comparison 34 Misoprostol versus oxytocin:…
34.9. Analysis
Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or…
34.9. Analysis Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or undefined cervix, Outcome 9 Neonatal intensive care unit admission.
34.10. Analysis
Comparison 34 Misoprostol versus oxytocin:…
34.10. Analysis
Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or…
34.10. Analysis Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or undefined cervix, Outcome 10 Postpartum haemorrhage.
34.11. Analysis
Comparison 34 Misoprostol versus oxytocin:…
34.11. Analysis
Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or…
34.11. Analysis Comparison 34 Misoprostol versus oxytocin: all women with ruptured membranes and variable or undefined cervix, Outcome 11 Vaginal delivery not achieved within 24 hours.
35.1. Analysis
Comparison 35 Misoprostol versus oxytocin:…
35.1. Analysis
Comparison 35 Misoprostol versus oxytocin: all women with previous caesarean section, Outcome 1…
35.1. Analysis Comparison 35 Misoprostol versus oxytocin: all women with previous caesarean section, Outcome 1 Vaginal delivery not achieved within 24 hours.
35.2. Analysis
Comparison 35 Misoprostol versus oxytocin:…
35.2. Analysis
Comparison 35 Misoprostol versus oxytocin: all women with previous caesarean section, Outcome 2…
35.2. Analysis Comparison 35 Misoprostol versus oxytocin: all women with previous caesarean section, Outcome 2 Caesarean section.
35.3. Analysis
Comparison 35 Misoprostol versus oxytocin:…
35.3. Analysis
Comparison 35 Misoprostol versus oxytocin: all women with previous caesarean section, Outcome 3…
35.3. Analysis Comparison 35 Misoprostol versus oxytocin: all women with previous caesarean section, Outcome 3 Serious maternal morbidity or death.
35.4. Analysis
Comparison 35 Misoprostol versus oxytocin:…
35.4. Analysis
Comparison 35 Misoprostol versus oxytocin: all women with previous caesarean section, Outcome 4…
35.4. Analysis Comparison 35 Misoprostol versus oxytocin: all women with previous caesarean section, Outcome 4 Uterine hyperstimulation without FHR changes.
35.5. Analysis
Comparison 35 Misoprostol versus oxytocin:…
35.5. Analysis
Comparison 35 Misoprostol versus oxytocin: all women with previous caesarean section, Outcome 5…
35.5. Analysis Comparison 35 Misoprostol versus oxytocin: all women with previous caesarean section, Outcome 5 Uterine rupture.
35.6. Analysis
Comparison 35 Misoprostol versus oxytocin:…
35.6. Analysis
Comparison 35 Misoprostol versus oxytocin: all women with previous caesarean section, Outcome 6…
35.6. Analysis Comparison 35 Misoprostol versus oxytocin: all women with previous caesarean section, Outcome 6 Meconium‐stained liquor.
35.7. Analysis
Comparison 35 Misoprostol versus oxytocin:…
35.7. Analysis
Comparison 35 Misoprostol versus oxytocin: all women with previous caesarean section, Outcome 7…
35.7. Analysis Comparison 35 Misoprostol versus oxytocin: all women with previous caesarean section, Outcome 7 Apgar score
35.8. Analysis
Comparison 35 Misoprostol versus oxytocin:…
35.8. Analysis
Comparison 35 Misoprostol versus oxytocin: all women with previous caesarean section, Outcome 8…
35.8. Analysis Comparison 35 Misoprostol versus oxytocin: all women with previous caesarean section, Outcome 8 Neonatal intensive care unit admission.
36.1. Analysis
Comparison 36 Misoprostol versus oxytocin:…
36.1. Analysis
Comparison 36 Misoprostol versus oxytocin: all women with previous caesarean section and unfavourable…
36.1. Analysis Comparison 36 Misoprostol versus oxytocin: all women with previous caesarean section and unfavourable cervix, Outcome 1 Vaginal delivery not achieved within 24 hours.
36.2. Analysis
Comparison 36 Misoprostol versus oxytocin:…
36.2. Analysis
Comparison 36 Misoprostol versus oxytocin: all women with previous caesarean section and unfavourable…
36.2. Analysis Comparison 36 Misoprostol versus oxytocin: all women with previous caesarean section and unfavourable cervix, Outcome 2 Caesarean section.
36.3. Analysis
Comparison 36 Misoprostol versus oxytocin:…
36.3. Analysis
Comparison 36 Misoprostol versus oxytocin: all women with previous caesarean section and unfavourable…
36.3. Analysis Comparison 36 Misoprostol versus oxytocin: all women with previous caesarean section and unfavourable cervix, Outcome 3 Serious maternal morbidity or death.
36.4. Analysis
Comparison 36 Misoprostol versus oxytocin:…
36.4. Analysis
Comparison 36 Misoprostol versus oxytocin: all women with previous caesarean section and unfavourable…
36.4. Analysis Comparison 36 Misoprostol versus oxytocin: all women with previous caesarean section and unfavourable cervix, Outcome 4 Uterine hyperstimulation without FHR changes.
36.5. Analysis
Comparison 36 Misoprostol versus oxytocin:…
36.5. Analysis
Comparison 36 Misoprostol versus oxytocin: all women with previous caesarean section and unfavourable…
36.5. Analysis Comparison 36 Misoprostol versus oxytocin: all women with previous caesarean section and unfavourable cervix, Outcome 5 Uterine rupture.
36.6. Analysis
Comparison 36 Misoprostol versus oxytocin:…
36.6. Analysis
Comparison 36 Misoprostol versus oxytocin: all women with previous caesarean section and unfavourable…
36.6. Analysis Comparison 36 Misoprostol versus oxytocin: all women with previous caesarean section and unfavourable cervix, Outcome 6 Meconium‐stained liquor.
36.7. Analysis
Comparison 36 Misoprostol versus oxytocin:…
36.7. Analysis
Comparison 36 Misoprostol versus oxytocin: all women with previous caesarean section and unfavourable…
36.7. Analysis Comparison 36 Misoprostol versus oxytocin: all women with previous caesarean section and unfavourable cervix, Outcome 7 Apgar score
36.8. Analysis
Comparison 36 Misoprostol versus oxytocin:…
36.8. Analysis
Comparison 36 Misoprostol versus oxytocin: all women with previous caesarean section and unfavourable…
36.8. Analysis Comparison 36 Misoprostol versus oxytocin: all women with previous caesarean section and unfavourable cervix, Outcome 8 Neonatal intensive care unit admission.
37.1. Analysis
Comparison 37 Misoprostol versus oxytocin:…
37.1. Analysis
Comparison 37 Misoprostol versus oxytocin: all multiparae, Outcome 1 Caesarean section.
37.1. Analysis Comparison 37 Misoprostol versus oxytocin: all multiparae, Outcome 1 Caesarean section.
37.2. Analysis
Comparison 37 Misoprostol versus oxytocin:…
37.2. Analysis
Comparison 37 Misoprostol versus oxytocin: all multiparae, Outcome 2 Serious neonatal morbidity.
37.2. Analysis Comparison 37 Misoprostol versus oxytocin: all multiparae, Outcome 2 Serious neonatal morbidity.
37.3. Analysis
Comparison 37 Misoprostol versus oxytocin:…
37.3. Analysis
Comparison 37 Misoprostol versus oxytocin: all multiparae, Outcome 3 Uterine hyperstimulation without FHR…
37.3. Analysis Comparison 37 Misoprostol versus oxytocin: all multiparae, Outcome 3 Uterine hyperstimulation without FHR changes.
37.4. Analysis
Comparison 37 Misoprostol versus oxytocin:…
37.4. Analysis
Comparison 37 Misoprostol versus oxytocin: all multiparae, Outcome 4 Instrumental delivery.
37.4. Analysis Comparison 37 Misoprostol versus oxytocin: all multiparae, Outcome 4 Instrumental delivery.
37.5. Analysis
Comparison 37 Misoprostol versus oxytocin:…
37.5. Analysis
Comparison 37 Misoprostol versus oxytocin: all multiparae, Outcome 5 Meconium‐stained liquor.
37.5. Analysis Comparison 37 Misoprostol versus oxytocin: all multiparae, Outcome 5 Meconium‐stained liquor.
37.6. Analysis
Comparison 37 Misoprostol versus oxytocin:…
37.6. Analysis
Comparison 37 Misoprostol versus oxytocin: all multiparae, Outcome 6 Neonatal intensive care unit…
37.6. Analysis Comparison 37 Misoprostol versus oxytocin: all multiparae, Outcome 6 Neonatal intensive care unit admission.
37.7. Analysis
Comparison 37 Misoprostol versus oxytocin:…
37.7. Analysis
Comparison 37 Misoprostol versus oxytocin: all multiparae, Outcome 7 Perinatal death.
37.7. Analysis Comparison 37 Misoprostol versus oxytocin: all multiparae, Outcome 7 Perinatal death.
37.8. Analysis
Comparison 37 Misoprostol versus oxytocin:…
37.8. Analysis
Comparison 37 Misoprostol versus oxytocin: all multiparae, Outcome 8 Maternal side effects (eg…
37.8. Analysis Comparison 37 Misoprostol versus oxytocin: all multiparae, Outcome 8 Maternal side effects (eg nausea, vomiting, diarrhoea).
37.9. Analysis
Comparison 37 Misoprostol versus oxytocin:…
37.9. Analysis
Comparison 37 Misoprostol versus oxytocin: all multiparae, Outcome 9 Postpartum haemorrhage.
37.9. Analysis Comparison 37 Misoprostol versus oxytocin: all multiparae, Outcome 9 Postpartum haemorrhage.
37.10. Analysis
Comparison 37 Misoprostol versus oxytocin:…
37.10. Analysis
Comparison 37 Misoprostol versus oxytocin: all multiparae, Outcome 10 Serious maternal complications.
37.10. Analysis Comparison 37 Misoprostol versus oxytocin: all multiparae, Outcome 10 Serious maternal complications.
38.1. Analysis
Comparison 38 Misoprostol versus oxytocin:…
38.1. Analysis
Comparison 38 Misoprostol versus oxytocin: all multiparae with unfavourable cervix, Outcome 1 Caesarean…
38.1. Analysis Comparison 38 Misoprostol versus oxytocin: all multiparae with unfavourable cervix, Outcome 1 Caesarean section.
38.2. Analysis
Comparison 38 Misoprostol versus oxytocin:…
38.2. Analysis
Comparison 38 Misoprostol versus oxytocin: all multiparae with unfavourable cervix, Outcome 2 Serious…
38.2. Analysis Comparison 38 Misoprostol versus oxytocin: all multiparae with unfavourable cervix, Outcome 2 Serious neonatal morbidity.
38.3. Analysis
Comparison 38 Misoprostol versus oxytocin:…
38.3. Analysis
Comparison 38 Misoprostol versus oxytocin: all multiparae with unfavourable cervix, Outcome 3 Uterine…
38.3. Analysis Comparison 38 Misoprostol versus oxytocin: all multiparae with unfavourable cervix, Outcome 3 Uterine hyperstimulation without FHR changes.
38.4. Analysis
Comparison 38 Misoprostol versus oxytocin:…
38.4. Analysis
Comparison 38 Misoprostol versus oxytocin: all multiparae with unfavourable cervix, Outcome 4 Instrumental…
38.4. Analysis Comparison 38 Misoprostol versus oxytocin: all multiparae with unfavourable cervix, Outcome 4 Instrumental delivery.
38.5. Analysis
Comparison 38 Misoprostol versus oxytocin:…
38.5. Analysis
Comparison 38 Misoprostol versus oxytocin: all multiparae with unfavourable cervix, Outcome 5 Neonatal…
38.5. Analysis Comparison 38 Misoprostol versus oxytocin: all multiparae with unfavourable cervix, Outcome 5 Neonatal intensive care unit admission.
38.6. Analysis
Comparison 38 Misoprostol versus oxytocin:…
38.6. Analysis
Comparison 38 Misoprostol versus oxytocin: all multiparae with unfavourable cervix, Outcome 6 Maternal…
38.6. Analysis Comparison 38 Misoprostol versus oxytocin: all multiparae with unfavourable cervix, Outcome 6 Maternal side effects.
38.7. Analysis
Comparison 38 Misoprostol versus oxytocin:…
38.7. Analysis
Comparison 38 Misoprostol versus oxytocin: all multiparae with unfavourable cervix, Outcome 7 Postpartum…
38.7. Analysis Comparison 38 Misoprostol versus oxytocin: all multiparae with unfavourable cervix, Outcome 7 Postpartum haemorrhage.
38.8. Analysis
Comparison 38 Misoprostol versus oxytocin:…
38.8. Analysis
Comparison 38 Misoprostol versus oxytocin: all multiparae with unfavourable cervix, Outcome 8 Meconium‐stained…
38.8. Analysis Comparison 38 Misoprostol versus oxytocin: all multiparae with unfavourable cervix, Outcome 8 Meconium‐stained liquor.
38.9. Analysis
Comparison 38 Misoprostol versus oxytocin:…
38.9. Analysis
Comparison 38 Misoprostol versus oxytocin: all multiparae with unfavourable cervix, Outcome 9 Perinatal…
38.9. Analysis Comparison 38 Misoprostol versus oxytocin: all multiparae with unfavourable cervix, Outcome 9 Perinatal death.
38.10. Analysis
Comparison 38 Misoprostol versus oxytocin:…
38.10. Analysis
Comparison 38 Misoprostol versus oxytocin: all multiparae with unfavourable cervix, Outcome 10 Serious…
38.10. Analysis Comparison 38 Misoprostol versus oxytocin: all multiparae with unfavourable cervix, Outcome 10 Serious maternal complications.
39.1. Analysis
Comparison 39 Misoprostol lower versus…
39.1. Analysis
Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 1 Vaginal delivery…
39.1. Analysis Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 1 Vaginal delivery not achieved within 24 hours.
39.2. Analysis
Comparison 39 Misoprostol lower versus…
39.2. Analysis
Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 2 Uterine hyperstimulation…
39.2. Analysis Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 2 Uterine hyperstimulation with FHR changes.
39.3. Analysis
Comparison 39 Misoprostol lower versus…
39.3. Analysis
Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 3 Caesarean section.
39.3. Analysis Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 3 Caesarean section.
39.4. Analysis
Comparison 39 Misoprostol lower versus…
39.4. Analysis
Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 4 Serious maternal…
39.4. Analysis Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 4 Serious maternal morbidity or death.
39.5. Analysis
Comparison 39 Misoprostol lower versus…
39.5. Analysis
Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 5 Cervix unfavourable/unchanged…
39.5. Analysis Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 5 Cervix unfavourable/unchanged after 12‐24 hours.
39.6. Analysis
Comparison 39 Misoprostol lower versus…
39.6. Analysis
Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 6 Oxytocin augmentation.
39.6. Analysis Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 6 Oxytocin augmentation.
39.7. Analysis
Comparison 39 Misoprostol lower versus…
39.7. Analysis
Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 7 Uterine hyperstimulation…
39.7. Analysis Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 7 Uterine hyperstimulation without FHR changes.
39.8. Analysis
Comparison 39 Misoprostol lower versus…
39.8. Analysis
Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 8 Uterine rupture.
39.8. Analysis Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 8 Uterine rupture.
39.9. Analysis
Comparison 39 Misoprostol lower versus…
39.9. Analysis
Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 9 Epidural.
39.9. Analysis Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 9 Epidural.
39.10. Analysis
Comparison 39 Misoprostol lower versus…
39.10. Analysis
Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 10 Instrumental vaginal…
39.10. Analysis Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 10 Instrumental vaginal delivery.
39.11. Analysis
Comparison 39 Misoprostol lower versus…
39.11. Analysis
Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 11 Meconium‐stained liquor.
39.11. Analysis Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 11 Meconium‐stained liquor.
39.12. Analysis
Comparison 39 Misoprostol lower versus…
39.12. Analysis
Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 12 Apgar score…
39.12. Analysis Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 12 Apgar score
39.13. Analysis
Comparison 39 Misoprostol lower versus…
39.13. Analysis
Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 13 Neonatal intensive…
39.13. Analysis Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 13 Neonatal intensive care unit admission.
39.14. Analysis
Comparison 39 Misoprostol lower versus…
39.14. Analysis
Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 14 Perinatal death.
39.14. Analysis Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 14 Perinatal death.
39.15. Analysis
Comparison 39 Misoprostol lower versus…
39.15. Analysis
Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 15 Maternal side…
39.15. Analysis Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 15 Maternal side effects (eg nausea, vomiting, diarrhoea).
39.16. Analysis
Comparison 39 Misoprostol lower versus…
39.16. Analysis
Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 16 Postpartum haemorrhage.
39.16. Analysis Comparison 39 Misoprostol lower versus higher dose: all women, Outcome 16 Postpartum haemorrhage.
40.1. Analysis
Comparison 40 Misoprostol lower versus…
40.1. Analysis
Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome…
40.1. Analysis Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome 1 Vaginal delivery not achieved within 24 hours.
40.2. Analysis
Comparison 40 Misoprostol lower versus…
40.2. Analysis
Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome…
40.2. Analysis Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome 2 Uterine hyperstimulation with FHR changes.
40.3. Analysis
Comparison 40 Misoprostol lower versus…
40.3. Analysis
Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome…
40.3. Analysis Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome 3 Caesarean section.
40.4. Analysis
Comparison 40 Misoprostol lower versus…
40.4. Analysis
Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome…
40.4. Analysis Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome 4 Uterine rupture.
40.5. Analysis
Comparison 40 Misoprostol lower versus…
40.5. Analysis
Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome…
40.5. Analysis Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome 5 Serious maternal morbidity or death.
40.6. Analysis
Comparison 40 Misoprostol lower versus…
40.6. Analysis
Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome…
40.6. Analysis Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome 6 Perinatal death.
40.7. Analysis
Comparison 40 Misoprostol lower versus…
40.7. Analysis
Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome…
40.7. Analysis Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome 7 Oxytocin augmentation.
40.8. Analysis
Comparison 40 Misoprostol lower versus…
40.8. Analysis
Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome…
40.8. Analysis Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome 8 Uterine hyperstimulation without FHR changes.
40.9. Analysis
Comparison 40 Misoprostol lower versus…
40.9. Analysis
Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome…
40.9. Analysis Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome 9 Epidural.
40.10. Analysis
Comparison 40 Misoprostol lower versus…
40.10. Analysis
Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome…
40.10. Analysis Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome 10 Instrumental vaginal delivery.
40.11. Analysis
Comparison 40 Misoprostol lower versus…
40.11. Analysis
Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome…
40.11. Analysis Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome 11 Meconium‐stained liquor.
40.12. Analysis
Comparison 40 Misoprostol lower versus…
40.12. Analysis
Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome…
40.12. Analysis Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome 12 Apgar score
40.13. Analysis
Comparison 40 Misoprostol lower versus…
40.13. Analysis
Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome…
40.13. Analysis Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome 13 Neonatal intensive care unit admission.
40.14. Analysis
Comparison 40 Misoprostol lower versus…
40.14. Analysis
Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome…
40.14. Analysis Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome 14 Maternal side effects (eg nausea, vomiting, diarrhoea).
40.15. Analysis
Comparison 40 Misoprostol lower versus…
40.15. Analysis
Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome…
40.15. Analysis Comparison 40 Misoprostol lower versus higher dose: all women with unfavourable cervix, Outcome 15 Postpartum haemorrhage.
41.1. Analysis
Comparison 41 Misoprostol lower versus…
41.1. Analysis
Comparison 41 Misoprostol lower versus higher dose: all women with intact membranes, Outcome…
41.1. Analysis Comparison 41 Misoprostol lower versus higher dose: all women with intact membranes, Outcome 1 Vaginal delivery not achieved in 24 hours.
41.2. Analysis
Comparison 41 Misoprostol lower versus…
41.2. Analysis
Comparison 41 Misoprostol lower versus higher dose: all women with intact membranes, Outcome…
41.2. Analysis Comparison 41 Misoprostol lower versus higher dose: all women with intact membranes, Outcome 2 Caesarean section.
41.3. Analysis
Comparison 41 Misoprostol lower versus…
41.3. Analysis
Comparison 41 Misoprostol lower versus higher dose: all women with intact membranes, Outcome…
41.3. Analysis Comparison 41 Misoprostol lower versus higher dose: all women with intact membranes, Outcome 3 Uterine hyperstimulation without FHR changes.
41.4. Analysis
Comparison 41 Misoprostol lower versus…
41.4. Analysis
Comparison 41 Misoprostol lower versus higher dose: all women with intact membranes, Outcome…
41.4. Analysis Comparison 41 Misoprostol lower versus higher dose: all women with intact membranes, Outcome 4 Meconium‐stained liquor.
42.1. Analysis
Comparison 42 Misoprostol lower versus…
42.1. Analysis
Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and…
42.1. Analysis Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and unfavourable cervix, Outcome 1 Vaginal delivery not achieved within 24 hours.
42.2. Analysis
Comparison 42 Misoprostol lower versus…
42.2. Analysis
Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and…
42.2. Analysis Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and unfavourable cervix, Outcome 2 Uterine hyperstimulation with FHR changes.
42.3. Analysis
Comparison 42 Misoprostol lower versus…
42.3. Analysis
Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and…
42.3. Analysis Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and unfavourable cervix, Outcome 3 Caesarean section.
42.4. Analysis
Comparison 42 Misoprostol lower versus…
42.4. Analysis
Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and…
42.4. Analysis Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and unfavourable cervix, Outcome 4 Serious maternal morbidity or death.
42.5. Analysis
Comparison 42 Misoprostol lower versus…
42.5. Analysis
Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and…
42.5. Analysis Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and unfavourable cervix, Outcome 5 Oxytocin augmentation.
42.6. Analysis
Comparison 42 Misoprostol lower versus…
42.6. Analysis
Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and…
42.6. Analysis Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and unfavourable cervix, Outcome 6 Uterine hyperstimulation without FHR changes.
42.7. Analysis
Comparison 42 Misoprostol lower versus…
42.7. Analysis
Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and…
42.7. Analysis Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and unfavourable cervix, Outcome 7 Instrumental vaginal delivery.
42.8. Analysis
Comparison 42 Misoprostol lower versus…
42.8. Analysis
Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and…
42.8. Analysis Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and unfavourable cervix, Outcome 8 Meconium‐stained liquor.
42.9. Analysis
Comparison 42 Misoprostol lower versus…
42.9. Analysis
Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and…
42.9. Analysis Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and unfavourable cervix, Outcome 9 Apgar score
42.10. Analysis
Comparison 42 Misoprostol lower versus…
42.10. Analysis
Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and…
42.10. Analysis Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and unfavourable cervix, Outcome 10 Neonatal intensive care unit admission.
42.11. Analysis
Comparison 42 Misoprostol lower versus…
42.11. Analysis
Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and…
42.11. Analysis Comparison 42 Misoprostol lower versus higher dose: all women with intact membranes and unfavourable cervix, Outcome 11 Maternal side effects (eg nausea, vomiting, diarrhoea).
43.1. Analysis
Comparison 43 Misoprostol lower versus…
43.1. Analysis
Comparison 43 Misoprostol lower versus higher dose: all multiparae, Outcome 1 Uterine hyperstimulation…
43.1. Analysis Comparison 43 Misoprostol lower versus higher dose: all multiparae, Outcome 1 Uterine hyperstimulation with FHR changes.
43.2. Analysis
Comparison 43 Misoprostol lower versus…
43.2. Analysis
Comparison 43 Misoprostol lower versus higher dose: all multiparae, Outcome 2 Caesarean section.
43.2. Analysis Comparison 43 Misoprostol lower versus higher dose: all multiparae, Outcome 2 Caesarean section.
43.3. Analysis
Comparison 43 Misoprostol lower versus…
43.3. Analysis
Comparison 43 Misoprostol lower versus higher dose: all multiparae, Outcome 3 Oxytocin augmentation.
43.3. Analysis Comparison 43 Misoprostol lower versus higher dose: all multiparae, Outcome 3 Oxytocin augmentation.
43.4. Analysis
Comparison 43 Misoprostol lower versus…
43.4. Analysis
Comparison 43 Misoprostol lower versus higher dose: all multiparae, Outcome 4 Uterine hyperstimulation…
43.4. Analysis Comparison 43 Misoprostol lower versus higher dose: all multiparae, Outcome 4 Uterine hyperstimulation without FHR changes.
43.5. Analysis
Comparison 43 Misoprostol lower versus…
43.5. Analysis
Comparison 43 Misoprostol lower versus higher dose: all multiparae, Outcome 5 Epidural.
43.5. Analysis Comparison 43 Misoprostol lower versus higher dose: all multiparae, Outcome 5 Epidural.
43.6. Analysis
Comparison 43 Misoprostol lower versus…
43.6. Analysis
Comparison 43 Misoprostol lower versus higher dose: all multiparae, Outcome 6 Instrumental vaginal…
43.6. Analysis Comparison 43 Misoprostol lower versus higher dose: all multiparae, Outcome 6 Instrumental vaginal delivery.
43.7. Analysis
Comparison 43 Misoprostol lower versus…
43.7. Analysis
Comparison 43 Misoprostol lower versus higher dose: all multiparae, Outcome 7 Meconium‐stained liquor.
43.7. Analysis Comparison 43 Misoprostol lower versus higher dose: all multiparae, Outcome 7 Meconium‐stained liquor.
43.8. Analysis
Comparison 43 Misoprostol lower versus…
43.8. Analysis
Comparison 43 Misoprostol lower versus higher dose: all multiparae, Outcome 8 Apgar score…
43.8. Analysis Comparison 43 Misoprostol lower versus higher dose: all multiparae, Outcome 8 Apgar score
43.9. Analysis
Comparison 43 Misoprostol lower versus…
43.9. Analysis
Comparison 43 Misoprostol lower versus higher dose: all multiparae, Outcome 9 Neonatal intensive…
43.9. Analysis Comparison 43 Misoprostol lower versus higher dose: all multiparae, Outcome 9 Neonatal intensive care unit admission.
43.10. Analysis
Comparison 43 Misoprostol lower versus…
43.10. Analysis
Comparison 43 Misoprostol lower versus higher dose: all multiparae, Outcome 10 Maternal side…
43.10. Analysis Comparison 43 Misoprostol lower versus higher dose: all multiparae, Outcome 10 Maternal side effects (eg nausea, vomiting, diarrhoea).
44.1. Analysis
Comparison 44 Misoprostol lower versus…
44.1. Analysis
Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome…
44.1. Analysis Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome 1 Vaginal delivery not achieved within 24 hours.
44.2. Analysis
Comparison 44 Misoprostol lower versus…
44.2. Analysis
Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome…
44.2. Analysis Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome 2 Uterine hyperstimulation with FHR changes.
44.3. Analysis
Comparison 44 Misoprostol lower versus…
44.3. Analysis
Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome…
44.3. Analysis Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome 3 Caesarean section.
44.4. Analysis
Comparison 44 Misoprostol lower versus…
44.4. Analysis
Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome…
44.4. Analysis Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome 4 Oxytocin augmentation.
44.5. Analysis
Comparison 44 Misoprostol lower versus…
44.5. Analysis
Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome…
44.5. Analysis Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome 5 Uterine hyperstimulation without FHR changes.
44.6. Analysis
Comparison 44 Misoprostol lower versus…
44.6. Analysis
Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome…
44.6. Analysis Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome 6 Epidural.
44.7. Analysis
Comparison 44 Misoprostol lower versus…
44.7. Analysis
Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome…
44.7. Analysis Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome 7 Instrumental vaginal delivery.
44.8. Analysis
Comparison 44 Misoprostol lower versus…
44.8. Analysis
Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome…
44.8. Analysis Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome 8 Meconium‐stained liquor.
44.9. Analysis
Comparison 44 Misoprostol lower versus…
44.9. Analysis
Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome…
44.9. Analysis Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome 9 Apgar score
44.10. Analysis
Comparison 44 Misoprostol lower versus…
44.10. Analysis
Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome…
44.10. Analysis Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome 10 Neonatal intensive care unit admission.
44.11. Analysis
Comparison 44 Misoprostol lower versus…
44.11. Analysis
Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome…
44.11. Analysis Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome 11 Postpartum haemorrhage.
44.12. Analysis
Comparison 44 Misoprostol lower versus…
44.12. Analysis
Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome…
44.12. Analysis Comparison 44 Misoprostol lower versus higher dose: all multiparae with unfavourable cervix, Outcome 12 Maternal side effects (eg nausea, vomiting, diarrhoea).
45.1. Analysis
Comparison 45 Misoprostol gel versus…
45.1. Analysis
Comparison 45 Misoprostol gel versus tablet: all women, Outcome 1 Uterine hyperstimulation with…
45.1. Analysis Comparison 45 Misoprostol gel versus tablet: all women, Outcome 1 Uterine hyperstimulation with FHR changes.
45.2. Analysis
Comparison 45 Misoprostol gel versus…
45.2. Analysis
Comparison 45 Misoprostol gel versus tablet: all women, Outcome 2 Caesarean section.
45.2. Analysis Comparison 45 Misoprostol gel versus tablet: all women, Outcome 2 Caesarean section.
45.3. Analysis
Comparison 45 Misoprostol gel versus…
45.3. Analysis
Comparison 45 Misoprostol gel versus tablet: all women, Outcome 3 Oxytocin augmentation.
45.3. Analysis Comparison 45 Misoprostol gel versus tablet: all women, Outcome 3 Oxytocin augmentation.
45.4. Analysis
Comparison 45 Misoprostol gel versus…
45.4. Analysis
Comparison 45 Misoprostol gel versus tablet: all women, Outcome 4 Epidural analgesia.
45.4. Analysis Comparison 45 Misoprostol gel versus tablet: all women, Outcome 4 Epidural analgesia.
45.5. Analysis
Comparison 45 Misoprostol gel versus…
45.5. Analysis
Comparison 45 Misoprostol gel versus tablet: all women, Outcome 5 Instrumental vaginal delivery.
45.5. Analysis Comparison 45 Misoprostol gel versus tablet: all women, Outcome 5 Instrumental vaginal delivery.
45.6. Analysis
Comparison 45 Misoprostol gel versus…
45.6. Analysis
Comparison 45 Misoprostol gel versus tablet: all women, Outcome 6 Apgar score
45.6. Analysis Comparison 45 Misoprostol gel versus tablet: all women, Outcome 6 Apgar score
45.7. Analysis
Comparison 45 Misoprostol gel versus…
45.7. Analysis
Comparison 45 Misoprostol gel versus tablet: all women, Outcome 7 Neonatal intensive care…
45.7. Analysis Comparison 45 Misoprostol gel versus tablet: all women, Outcome 7 Neonatal intensive care unit admission.
46.1. Analysis
Comparison 46 Misoprostol gel versus…
46.1. Analysis
Comparison 46 Misoprostol gel versus tablet: all women with unfavourable cervix, Outcome 1…
46.1. Analysis Comparison 46 Misoprostol gel versus tablet: all women with unfavourable cervix, Outcome 1 Uterine hyperstimulation with FHR changes.
46.2. Analysis
Comparison 46 Misoprostol gel versus…
46.2. Analysis
Comparison 46 Misoprostol gel versus tablet: all women with unfavourable cervix, Outcome 2…
46.2. Analysis Comparison 46 Misoprostol gel versus tablet: all women with unfavourable cervix, Outcome 2 Caesarean section.
46.3. Analysis
Comparison 46 Misoprostol gel versus…
46.3. Analysis
Comparison 46 Misoprostol gel versus tablet: all women with unfavourable cervix, Outcome 3…
46.3. Analysis Comparison 46 Misoprostol gel versus tablet: all women with unfavourable cervix, Outcome 3 Oxytocin augmentation.
46.4. Analysis
Comparison 46 Misoprostol gel versus…
46.4. Analysis
Comparison 46 Misoprostol gel versus tablet: all women with unfavourable cervix, Outcome 4…
46.4. Analysis Comparison 46 Misoprostol gel versus tablet: all women with unfavourable cervix, Outcome 4 Epidural analgesia.
46.5. Analysis
Comparison 46 Misoprostol gel versus…
46.5. Analysis
Comparison 46 Misoprostol gel versus tablet: all women with unfavourable cervix, Outcome 5…
46.5. Analysis Comparison 46 Misoprostol gel versus tablet: all women with unfavourable cervix, Outcome 5 Instrumental vaginal delivery.
46.6. Analysis
Comparison 46 Misoprostol gel versus…
46.6. Analysis
Comparison 46 Misoprostol gel versus tablet: all women with unfavourable cervix, Outcome 6…
46.6. Analysis Comparison 46 Misoprostol gel versus tablet: all women with unfavourable cervix, Outcome 6 Apgar score
46.7. Analysis
Comparison 46 Misoprostol gel versus…
46.7. Analysis
Comparison 46 Misoprostol gel versus tablet: all women with unfavourable cervix, Outcome 7…
46.7. Analysis Comparison 46 Misoprostol gel versus tablet: all women with unfavourable cervix, Outcome 7 Neonatal intensive care unit admission.
All figures (450)
Cited by
-
Mechanical methods for induction of labour. de Vaan MD, Ten Eikelder ML, Jozwiak M, Palmer KR, Davies-Tuck M, Bloemenkamp KW, Mol BWJ, Boulvain M. de Vaan MD, et al. Cochrane Database Syst Rev. 2023 Mar 30;3(3):CD001233. doi: 10.1002/14651858.CD001233.pub4. Cochrane Database Syst Rev. 2023. PMID: 36996264 Review.
-
-
-
Pharmacokinetics of vaginal versus buccal misoprostol for labor induction at term. Vorontsova Y, Haas DM, Flannery K, Masters AR, Silva LL, Pierson RC, Yeley B, Hogg G, Guise D, Heathman M, Quinney SK. Vorontsova Y, et al. Clin Transl Sci. 2022 Aug;15(8):1937-1945. doi: 10.1111/cts.13306. Epub 2022 Jun 12. Clin Transl Sci. 2022. PMID: 35587540 Free PMC article. Clinical Trial.
-
MeSH terms
Administration, Intravaginal
Misoprostol / administration & dosage*
Oxytocics / administration & dosage*
Pregnancy Trimester, Third
Randomized Controlled Trials as Topic
LinkOut - more resources
- Full Text Sources
- Other Literature Sources
- Medical
- Miscellaneous
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM
NCBI Literature Resources
MeSH PMC Bookshelf Disclaimer
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
Follow NCBI